Academic Reading Articles Practice 17 Test 03

A
Sleep is sometimes described as a simple absence of wakefulness, as if the brain merely “switches off” for a number of hours. In physiological terms, however, sleep is an actively organised state, regulated by specialised neural circuits and characterised by recurring stages that can be measured in the laboratory. Across a typical night, the brain alternates between non-rapid eye movement (NREM) sleep and rapid eye movement (REM) sleep in cycles that last roughly 90 minutes, with the balance between stages shifting as morning approaches. These stages differ in electrical activity, autonomic regulation, and muscle tone, and they appear to support different forms of biological maintenance. Understanding sleep, therefore, requires treating it not as a passive pause, but as a dynamic process in which the brain repeatedly changes its operating mode.

B
Two internal regulatory mechanisms largely determine when sleep begins and how it unfolds. The first is the circadian timing system, whose “master clock” is located in the suprachiasmatic nucleus (SCN) of the hypothalamus. The SCN is entrained primarily by light: bright morning exposure tends to stabilise timing, whereas intense evening light—especially short-wavelength light from screens—can shift the clock later. The second mechanism is the homeostatic sleep drive, which increases with time awake and makes sleep progressively more likely. This pressure is linked to the accumulation of adenosine in the brain; caffeine can delay sleep onset because it blocks adenosine receptors, reducing the felt force of the homeostatic signal without removing the underlying need for sleep. In practice, sleep timing emerges from the interaction between circadian alerting signals and homeostatic pressure, rather than from willpower alone.

C
Within NREM sleep, the deepest stage—slow-wave sleep—is associated with pronounced changes in brain activity and physiology. Slow waves reflect highly synchronised neural firing, and this stage is often linked to physical restoration, including endocrine regulation and aspects of immune signalling. In recent years, research has also highlighted a potential “clearance” function: during deep NREM sleep, the space between brain cells appears to expand, allowing cerebrospinal fluid to circulate more freely through perivascular channels. This activity, commonly discussed under the label of the glymphatic system, may help wash away metabolic waste produced during wakefulness. Although the details remain an active research area, the central implication is that deep sleep may support a form of neural housekeeping that is less efficient when the brain is fully engaged with sensory input and continuous thought.

D
REM sleep, in contrast, is marked by rapid eye movements, a distinctive pattern of brain activation, and a temporary suppression of major voluntary muscles, sometimes called REM atonia. Dreaming is especially vivid in this stage, and researchers often associate REM with emotional processing and certain types of memory integration. Rather than storing information as isolated fragments, the sleeping brain may weave new experiences into existing knowledge networks, helping later recall become more fluent and meaning-based. Crucially, however, sleep’s contribution to learning is not confined to REM. Different memory systems appear to benefit from different phases: some procedural skills improve after repeated cycles across the night, while aspects of declarative memory may relate more strongly to NREM features such as slow waves and sleep spindles. The emerging picture is therefore one of division of labour, with REM contributing to some forms of consolidation and regulation, and NREM supporting others.

E
When sleep is curtailed, the consequences are not limited to feeling drowsy. Laboratory studies show that restricted sleep can slow reaction time, increase lapses of sustained attention, and impair working memory—effects that become particularly dangerous in low-stimulation situations such as late-night driving or monitoring tasks. One especially problematic feature is reduced awareness of impairment. Sleep-deprived individuals often report that they are coping reasonably well, even as objective performance deteriorates. This mismatch between confidence and capability matters for safety, because it encourages people to take risks they would avoid if they accurately perceived their limitations. In other words, sleep loss can damage both attention and the ability to judge one’s own attentional failure.

F
Contemporary living frequently conflicts with sleep biology, and the mismatch is amplified by certain disorders. Shift work can force sleep to occur when the circadian system promotes alertness, producing chronic misalignment that may affect mood, metabolism, and accident risk. Long commutes, irregular schedules, and late-night device use can fragment sleep and weaken circadian stability. At the same time, some problems persist even when people spend adequate time in bed. Obstructive sleep apnoea, for example, involves repeated breathing interruptions that reduce oxygen and trigger brief arousals, preventing restorative architecture despite apparently “long” sleep. Insomnia, by contrast, often involves difficulty initiating or maintaining sleep and can be sustained by conditioned arousal—worry about sleep becomes, paradoxically, a factor that blocks it. These cases illustrate why sleep quality and timing can matter as much as duration.

G
Because sleep is regulated, it can also be supported through targeted habits and environments. Sleep researchers commonly recommend consistent wake times to anchor the circadian system, since irregular wake-up schedules can shift internal timing from day to day. Light management is equally important: bright morning exposure helps stabilise the SCN, while reducing intense light in the evening lowers the risk of circadian delay. A cooler, darker, quieter bedroom can support sleep onset by reducing physiological arousal, and limiting late caffeine avoids artificially weakening the homeostatic signal. Where disorders are suspected, behavioural strategies may need to be combined with medical assessment rather than relying on generic advice. Overall, sleep science portrays rest as a multi-function biological state—shaped by internal clocks, homeostatic pressure, and modern environments—and therefore as something that can be protected through informed choices rather than treated as optional spare time.

A
For much of the late twentieth century, public health advice in several high-income countries treated dietary fat as a primary driver of weight gain and heart disease. The message was memorable partly because it was numerically simple: fat contains more energy per gram than carbohydrate or protein, so reducing fat intake appeared a direct route to lowering calories. Public campaigns and food labels reinforced this logic, and manufacturers reformulated products to advertise “low-fat” credentials. Yet the apparent clarity hid an important ambiguity: whether reducing fat improved health depended on which fats were being reduced, what replaced them, and how overall dietary patterns changed as a result.

B
The historical origins of fat-focused guidelines are often associated with a period when cardiovascular disease was rising and epidemiological research sought broad dietary explanations. Ancel Keys’ Seven Countries Study, frequently cited in this context, suggested that populations consuming more saturated fat tended to show higher average blood cholesterol and higher rates of heart disease. Such findings were influential, but they were also correlational: observational patterns can reveal associations across populations without demonstrating direct causation in individuals. Moreover, factors such as smoking prevalence, physical activity, medical care, and food availability differ across countries and can complicate interpretation. Nevertheless, the combination of a plausible biological pathway and an urgent public health problem made low-fat advice politically attractive and scientifically defensible—at least within the limits of the evidence then available.

C
As research accumulated, the conversation shifted from “fat” as a single category to fat as a set of chemically distinct substances with different effects on the lipid profile. Saturated fats tend to raise LDL cholesterol, a particle strongly linked to atherosclerotic plaque formation, although they may also raise HDL cholesterol, which is often treated as protective. Unsaturated fats—especially polyunsaturated fats—can lower LDL when they replace saturated fats, improving cardiovascular risk markers in many studies. Trans fats, produced industrially in partially hydrogenated oils, became a pivotal example: they raise LDL while lowering HDL, and they are associated with increased risk, which led many jurisdictions to restrict or effectively eliminate them from the food supply. This nuance undermined the earlier “total fat” framing and forced a more mechanistic question: which substitution produces the most favourable metabolic outcome?

D
A second turning point involved the unintended consequences of translating nutrient advice into commercial food products. When fat was reduced in processed foods, palatability often had to be restored, and manufacturers frequently relied on refined starches or sweetness. This produced what some commentators called the “SnackWell effect”: consumers interpreted “low-fat” as a health guarantee and ate larger portions, while the products themselves could be energy-dense and rapidly absorbed. In many diets, therefore, reduced fat did not automatically reduce calories; instead, fat was replaced by refined carbohydrates and added sugars, contributing to high glycaemic loads and—among susceptible individuals—worsening markers associated with metabolic syndrome. The episode became a cautionary tale about nutrient-by-nutrient messaging: a guideline can be logically correct in theory yet generate counterproductive outcomes when it is implemented through highly processed substitutions.

E
Disagreement persisted partly because nutrition science is methodologically constrained. Randomised controlled trials are regarded as the strongest design for causal inference, but long-term trials that control entire diets are expensive and difficult to maintain, and participant adherence tends to decline over time. As a result, evidence often comes from shorter interventions using surrogate endpoints (such as LDL levels), combined with large observational studies tracking disease outcomes. Observational work, however, frequently relies on food-frequency questionnaires and other self-reported measures, which are vulnerable to recall error and social desirability bias. Confounding is another challenge: people who choose certain fats may also differ in education, exercise, smoking, and healthcare access. These limitations do not make guideline development impossible, but they help explain why expert panels sometimes weigh the same body of evidence differently and why public advice can appear to “change its mind.”

F
A further complication is that dietary effects are not uniform across individuals. Genetic variability influences lipid metabolism, and the same macronutrient ratio can produce different blood markers in different people. The gut microbiome may also mediate how foods are processed, generating metabolites that interact with inflammation and insulin sensitivity. Activity levels, medication use, and existing cardiometabolic risk shape the consequences of dietary change, so a substitution that improves one person’s lipid profile may have a smaller effect in another. This has encouraged interest in “precision” or personalised nutrition, but critics note that commercial personalised claims can outrun clinical evidence, especially when recommendations are based on limited biomarkers or short-term responses rather than long-term outcomes. The safest inference, therefore, is not that guidelines are useless, but that population advice inevitably simplifies a biologically heterogeneous reality.

G
In recent decades, many guidelines have moved toward pattern-based recommendations that incorporate these lessons. Rather than prescribing a single percentage of total fat, modern advice typically emphasises food quality and substitution: minimise trans fats, limit saturated fat, and preferentially use unsaturated sources from nuts, seeds, fish, and plant oils—particularly when they replace refined carbohydrates. Dietary patterns such as Mediterranean-style eating have become influential because they describe a food matrix—vegetables, legumes, whole grains, and healthy fats—rather than isolating one nutrient. This approach also acknowledges that the same nutrient can behave differently depending on the broader diet and processing level. The central message of the “fat debate,” then, is not a dramatic reversal but a refinement: health outcomes depend on the type of fat, the quality of the diet, and the trade-offs created by what people eat instead.

Taxes on sugar-sweetened beverages have become one of the most contested public-health instruments of recent decades. Their stated purpose is straightforward: to reduce the consumption of products strongly associated with excess energy intake and, by extension, obesity, type 2 diabetes and dental decay. The controversy arises because the policy sits at the intersection of economics, psychology and ethics. To some, a beverage tax represents a rational correction to distorted prices; to others, it is a symbolic “quick fix” imposed on a complex dietary landscape, and a step toward paternalistic governance.

From an economic perspective, the case for a sugar tax is usually framed as a response to negative externalities—costs imposed on third parties that are not captured by the market price of the product. When high sugar intake contributes to preventable illness, part of the resulting burden is paid collectively through insurance pools and publicly funded healthcare. In that context, the tax resembles a Pigovian tax: a levy designed to align private purchase decisions with broader social costs. Supporters argue that without such a correction, consumers face an artificially low price signal, while producers profit without fully accounting for downstream consequences. Critics respond that externality arguments are often stretched beyond their legitimate scope, because many health conditions have multiple causes and because the magnitude of social cost is difficult to attribute to a single commodity.

A second strand of argument concerns behaviour rather than accounting. The effectiveness of taxation depends on the price elasticity of demand: the degree to which purchasing falls when price rises. Sugary drinks are frequently described as discretionary rather than essential, implying that consumers may be responsive to a price increase. Yet elasticity is not a fixed number; it varies across populations, brands and contexts, and is shaped by how the tax is implemented. If retailers absorb some of the levy to protect market share, consumers may see only a modest change at the shelf. Conversely, if the tax is clearly passed through—sometimes even highlighted on receipts—it can become a salient signal that triggers habit disruption. In this way, a tax functions partly like a “nudge” and partly like a “shove”: it alters the choice architecture by changing relative prices, but it does so through compulsion rather than gentle steering.

Policy design often determines whether the mechanism extends beyond consumer choice to reshape supply. A flat charge per litre treats all sugary beverages as equivalent, whereas a tiered structure taxes drinks according to sugar concentration. The latter is intended to reward lower sugar formulations and penalise higher ones, encouraging manufacturers to reformulate products to avoid the most expensive bracket. Supporters present this as a distinctive advantage: even if total beverage volume changes only marginally, the sugar content of what is sold can decline as producers alter recipes, portion sizes, or product portfolios. Opponents note that reformulation is not cost-free. Firms may substitute sweeteners that are controversial in their own right, or concentrate marketing on untaxed variants to preserve sales, shifting the commercial landscape without necessarily improving diet quality overall.

The ethical debate is often dominated by a single term: regressivity. Because low-income households spend a larger share of income on consumables, a consumption tax can represent a heavier proportional burden. For critics, this is not a peripheral issue but a central indictment: a health policy should not rely on financial penalties that fall most sharply on those least able to absorb them. Proponents counter that the distribution of health harm is also unequal. Diet-related disease frequently clusters in disadvantaged communities due to constrained food environments, stress, and limited access to preventive care. If a tax reduces consumption most in these groups, the policy could generate progressive health benefits even if the financial incidence is regressive. On this view, fairness is judged not only by who pays, but by who gains in avoided illness and improved quality of life.

Because public acceptance often hinges on perceived legitimacy, the use of revenue becomes politically decisive. When governments earmark proceeds for visible health programmes—school meal improvements, community sport facilities, or subsidies for fruit and vegetables—the tax can be framed as a collective investment rather than a punitive revenue grab. Earmarking may also address the equity critique by channeling resources toward the communities most affected by diet-related harms. However, earmarks can be unstable: fiscal pressures may tempt policymakers to divert funds into general budgets, undermining trust. Furthermore, a narrow earmark may create the impression that the policy’s primary goal is funding rather than behaviour change, which can weaken the moral narrative of a Pigovian intervention.

No serious appraisal of sugar taxes can ignore unintended effects. Consumers may substitute to other high-calorie products, limiting net reductions in energy intake. Cross-border shopping can arise when neighbouring jurisdictions set different tax rates, particularly in areas where travel is easy and price differences are salient. Small retailers may face administrative burdens, especially if compliance systems are complex or if product classification is unclear. Industry, for its part, is rarely passive: firms can adjust promotions, package sizes, and branding strategies to blunt the intended price signal. In economic terms, the policy triggers strategic responses along the supply chain, so measured effects on sales may not translate directly into longer-term health outcomes.

Evaluation therefore becomes a methodological challenge. Taxes are implemented in real societies, not laboratories, and they often coincide with other interventions such as advertising restrictions, school nutrition reforms, or shifts in consumer awareness. Researchers typically rely on sales datasets, household purchasing panels, and population surveys, triangulating evidence to infer what changed after implementation. Yet establishing causality remains difficult, particularly for outcomes like obesity or diabetes that evolve over long time horizons and are influenced by multiple behaviours beyond beverage intake. For that reason, claims of immediate, nationwide reductions in chronic disease would be implausible even if consumption changes are observed quickly. The most defensible research questions are incremental: whether purchases shift, whether reformulation occurs, and whether the policy’s effects persist rather than fade as consumers adapt.

The broader philosophical dispute is ultimately about the role of the state in shaping everyday consumption. A tax can be interpreted as an intrusion into personal choice, especially when individuals resent being charged for behaviour that carries future risk rather than immediate harm. Yet public health has long relied on interventions—seatbelt laws, tobacco regulation, sanitation—whose benefits are collective and whose logic is preventative. The strongest defence of sugar taxes is therefore pragmatic rather than utopian: they are unlikely to “solve” obesity, but they may contribute to a portfolio of policies that gradually shifts norms, reduces sugar exposure, and funds prevention. In that portfolio view, the relevant standard is not perfection, but whether the tool produces measurable improvement without disproportionate harm.